The hearing of New Horizon Health's (HKG:6606) joint provisional liquidator application with the Grand Court of the Cayman Islands has been scheduled at 10 am on Aug. 6, a Friday Hong Kong bourse filing said.
The cancer screening test developer had filed the application in early July.
If appointed, the joint provisional liquidators will conduct investigations into the firm's affairs, in particular, certain concerns raised by the company's auditors in relation to its 2023 annual results.
The auditor raised questions on the validity of certain sales transactions, as well as marketing and selling expenses among other things, according to a March 2024 disclosure.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。